VYOME HOLDINGS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $201.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $215.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $416.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $0.00.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- VYOME HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $53.00K, a 71.20% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $416.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $201.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $215.00K 10-Q · filed 2022-08-19 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-11-06 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2019-09-30 | $14.72M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-03-31 | $1.00K 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $53.00K 10-K · filed 2020-02-27 | |
| 2018-09-30 | $7.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $3.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $28.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $184.00K 10-K · filed 2019-02-22 | |
| 2016-12-31 | $820.00K 10-K · filed 2018-03-05 | |
| 2015-12-31 | $62.00K 10-K · filed 2018-03-05 | |
| 2014-12-31 | $8.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |